BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.310
+0.060 (4.80%)
At close: Jun 26, 2026, 4:00 PM EDT
1.300
-0.010 (-0.76%)
After-hours: Jun 26, 2026, 7:53 PM EDT
BioXcel Therapeutics Employees
BioXcel Therapeutics had 29 employees as of December 31, 2025. The number of employees decreased by 8 or -21.62% compared to the previous year.
Employees
29
Change (1Y)
-8
Growth (1Y)
-21.62%
Revenue / Employee
$23,448
Profits / Employee
-$2,597,724
Market Cap
40.45M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 285 |
| Zhengye Biotechnology Holding | 269 |
| China Pharma Holdings | 215 |
| Rockwell Medical | 157 |
| Aytu BioPharma | 83 |
| SCYNEXIS | 18 |
| Incannex Healthcare | 12 |
| Talphera | 12 |
BTAI News
- 4 weeks ago - BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual Meeting - GlobeNewsWire
- 6 weeks ago - BioXcel Therapeutics reports Q1 EPS (54c), consensus (49c) - TheFly
- 6 weeks ago - BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 6 weeks ago - BioXcel Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - BioXcel Therapeutics Earnings release: Q1 2026 - Filings
- 2 months ago - BioXcel Therapeutics Transcript: Investor update - Transcripts
- 2 months ago - BioXcel Therapeutics Slides: Investor update - Filings
- 2 months ago - BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting - GlobeNewsWire